Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

MDxI Launches LabFile Data Resource

Published: Friday, July 25, 2014
Last Updated: Thursday, July 24, 2014
Bookmark and Share
New standard for defining and targeting US clinical laboratory universe.

Market Diagnostics International LLC has announced the availability of IVD Insights™ LabFile, a data resource that sets a new standard for defining the US clinical laboratory universe and identifying target In Vitro Diagnostics (IVD) customers.

LabFile is a proprietary database that provides IVD manufacturers with accurate and comprehensive information on sites performing clinical tests, relying on clear and consistent definitions of laboratory categories and institutional affiliations.

LabFile is based on MDxI’s extensive site research and industry knowledge and is a highly informative tool for defining market opportunities and targets.

“Our work with IVD clients indicated that even sophisticated companies had incomplete, often conflicting information about existing customers, and they were struggling to accurately identify and target new customers. Many also were spending considerable resources to update and refine their CRM systems, often with unsatisfactory results,” commented Kathi McGregor, President and Managing Partner of MDxI.

McGregor continued, “LabFile was developed to address these issues. Over the past two years, we obtained input from manufacturers about what was missing in their own databases and then invested thousands of hours in developing LabFile, the most rigorously designed and compiled clinical laboratory database to date. We also are providing customers with quarterly updates to capture the ever-changing nature of the laboratory market.”

Unlike other industry data resources, which assume that the 200,000+ CLIA licenses equal an equivalent number of unique laboratories, LabFile takes into account the expansion of health care delivery networks and resulting consolidation of laboratory testing.

Currently, LabFile identifies and classifies nearly 14,000 verified sites for targeting out of the estimated 18,000 US labs performing moderate to high complexity IVD testing. The number of verified, profiled sites will continue to grow as the product is expanded, with such added details as identifying sites that perform only CLIA-waived testing.

Updated quarterly, LabFile is a valuable resource for cleaning, maintaining, and reconciling current CRM data or establishing new CRM systems.

Reports are easily segmented and targeted for specific purposes, using clearly defined and standardized classification of laboratory types, subtypes, and network affiliations.

Coupled with MDxI’s IVD Insights Reports, LabFile presents the clearest picture of the configuration and depth of the US IVD market available.

To learn more about IVD Insights™ LabFile, visit Booth #1679 at the 2014 AACC Annual Meeting in Chicago, IL, July 27-31, 2014.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Bioreactors Ready for the Big Time
Bioreactors are passive filtration systems that can reduce nitrate losses from farm fields.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!